Apogee (APOG) Director Adds 39 Deferred RSUs, Now Holds 6,796 Shares

Rhea-AI Filing Summary

Lilly Elizabeth Murphy, a director of Apogee Enterprises, Inc. (APOG), reported a change in beneficial ownership dated 09/30/2025. The filing shows acquisition of 39 deferred restricted stock units (RSUs) allocated under the 2019 Non-Employee Director Stock Plan at an indicated price of $43.57. The RSUs settle 1-for-1 into common stock on termination or other plan-specified events. Following the transaction, the reporting person beneficially owns 6,796 shares directly. The RSUs include dividend equivalent reinvestment credits.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lilly Elizabeth Murphy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Restricted Stock Units	39	$43.57	$2K

Holdings After Transaction: Deferred Restricted Stock Units — 6,796 shares (Direct)

Footnotes (1)

1. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan. Settled 1-for-1. Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lilly Elizabeth Murphy

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MN 55435

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units(1)	(2)	09/30/2025		A(3)		39		(1)	(1)	Common Stock	39	$43.57	6,796	D

Explanation of Responses:

1. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.

2. Settled 1-for-1.

3. Additional deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.

Remarks:

	/s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for APOG?

The Form 4 was filed on behalf of Lilly Elizabeth Murphy, a director of Apogee Enterprises, Inc. (APOG).

What transaction is reported on the Form 4 dated 09/30/2025 for APOG?

The report shows acquisition of 39 deferred restricted stock units (RSUs) under the 2019 Non-Employee Director Stock Plan on 09/30/2025.

What is the settlement and conversion detail for the RSUs?

The RSUs are settled 1-for-1 into common stock following the director's termination or other plan-specified events.

How many shares does the reporting person beneficially own after this transaction?

The reporting person beneficially owns 6,796 shares of common stock following the reported transaction.

Was there a price reported for the derivative securities on the Form 4?

The filing shows an indicated price of $43.57 associated with the reported RSUs in the transaction table.